Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rankning i aktier #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aktiekurs
$0.16240909
Senast synkroniserad: 2025-03-04
Marknadsvärde
$35.68M
Förändring (1 dag)
0.27%
Förändring (1 år)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategori

Utdelningsavkastning för Dali Pharmaceuticalco.,Ltd (603963)
Utdelningsavkastningen (TTM) för Dali Pharmaceuticalco.,Ltd (aktiesymbol: 603963) per 2022-12-31 är: 0.08%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.24%
Historik för utdelningsavkastning för Dali Pharmaceuticalco.,Ltd (603963) från 2012 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
2026 (TTM) 0.00% -100.00%
2023 0.06% -25.00%
2022 0.08% -84.62%
2021 0.52% 1,633.33%
2020 0.03% -94.23%
2019 0.52% -21.21%
2018 0.66% -76.00%
2017 2.75% -59.80%
2016 6.84% -18.18%
2015 8.36% -14.69%
2014 9.80% 15.70%
2013 8.47% 9,311.11%
2012 0.09% 0.00%
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter